More Evidence for Neurofilament Light Chain as MS Biomarker

Tracking sNfL levels over time corresponds to multiple sclerosis disease course in a longitudinal study, but use of the blood biomarker for individual prognosis remains unclear.
Medscape Medical News

Source link

Related posts

Spotlight on the February 18 issue


Cannabis addiction influenced by genetic make-up


SPD in Summertime


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World